Spiber Technologies AB is a biotechnology company based in Stockholm that specializes in the development and production of proprietary recombinant spider silk proteins. The company focuses on innovative biomaterials, leveraging its unique ability to bioactivate spider silk for various applications. Spiber engages in research and development initiatives to advance its technologies and has developed the Spiber SolvNT® technology, which is part of its proprietary offerings.
The company collaborates with leading academic research centers to enhance its technological capabilities and contribute to the field of biomaterials. Spiber has been featured in various publications and news events, highlighting its advancements and contributions to biotechnology. Additionally, the company provides educational resources, including featured videos, to disseminate knowledge about its technologies and the potential applications of spider silk proteins. Spiber Technologies AB actively participates in industry events and issues press releases to share updates on its progress and initiatives.
